SGLT-2 Inhibitors, An Issue of Heart Failure Clinics, 1st Edition
In this issue, guest editors bring their considerable expertise to this important topic.
Key Features
Provides in-depth reviews on the latest updates in the field, providing actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create these timely topic-based reviews.
Author Information
Edited by Deepak L. Bhatt, MD, MPH, Executive Director of Interventional Cardiovascular Programs, Brigham and Women’s Hospital Heart and Vascular Center; Professor of Medicine, Harvard Medical School, Boston, Massachusetts, USA and Ragavendra R. Baliga, MD, MBA, FACP, FRCP, FACC, Inaugural Director, Cardio-Oncology Center of Excellence Professor of Internal Medicine The Ohio State University Wexner Medical Center
